Overview

We aim to contribute on future medicine by developing practical and efficient technologies and evaluation methodologies in the field of nuclear medicine (PET and SPECT) and related imaging modalities.

Contact and Access

Department of Quantum Science and Energy Engineering
6-6-01-2, Aramaki Aza Aoba Aoba-ku, Sendai, Miyagi 980-8579, Japan
E-mail: miho.shidahara.c2@tohoku.ac.jp
TEL�F+81-22-795-7928
Research Building-M.A.E.

Members

Professor

Shigeo Matsuyama

Professor

Associate professor

Miho Shidahara

Asscoiate Professor

Research staff

Shoichi Watanuki

Research fellow

Doctor student

PHORNPAILIN PAIRODSANTIKUL (Ploy)

D1

Master Student

Hayato Abe

M2

Master Student

Atsuya Hino

M2

Master Student

PHILIPPE PHONEMY

M1(DDprogram, EC-Lyon)

Master Student

Mei Takahashi

M1

Master Student

Hiroto Chiba

M1

Bachelor Student

Wataru kageyama

B4

Bachelor Student

Mizuki Matsushita

B4

Bachelor Student

Jin Nakasyo

B3

Bachelor Student

Yuzuki Masuda

B3

Research projects

Pic 01

Quantification of physiological functions

Quantification of functional imaging can be degraded by limited spatial resolution, incomplete processing, subject�fs motions and so on. To improve the quantification, we are developing methodologies for motion correction and image-processing.

Pic 02

Computer-aided virtual clinical trial for efficient development of radioligands

Computer-aided virtual clinical trial is a kind of simulation techniques for human body but its application have great potential as before having clinical trial in many ways. We try to develop the system for efficient development of radioligands.

Pic 02

Numerical observer model for prediction of diagnostic ability in medical imaging

Lesion-detection ability is one of important diagnostic factors for medical imaging. We try to predict the impact of introducing new technologies by numerical observer model.

Pic 02

Radiation dosimetry in both diagnostic and therapeutic purposes

Internal radiation exposure in nuclear medicine is inevitable and have to be estimated for risk-benefit management. Human radiation dose suffered from nuclear medicine can be estimated from time-series measurement of the biodistribution of the injected radioligand. We aim to develop noninvasive methodologies further practical applications.